BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2005582)

  • 1. Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948.
    Clineschmidt BV; Pettibone DJ; Reiss DR; Lis EV; Haluska GJ; Novy MJ; Cook MJ; Cukierski MA; Kaufman MJ; Bock MG
    J Pharmacol Exp Ther; 1991 Mar; 256(3):827-32. PubMed ID: 2005582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro pharmacological profile of a novel structural class of oxytocin antagonists.
    Pettibone DJ; Clineschmidt BV; Lis EV; Reiss DR; Totaro JA; Woyden CJ; Bock MG; Freidinger RM; Tung RD; Veber DF
    J Pharmacol Exp Ther; 1991 Jan; 256(1):304-8. PubMed ID: 1988661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an orally active, nonpeptidyl oxytocin antagonist.
    Pettibone DJ; Clineschmidt BV; Kishel MT; Lis EV; Reiss DR; Woyden CJ; Evans BE; Freidinger RM; Veber DF; Cook MJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):308-14. PubMed ID: 8423533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
    Flouret G; Chaloin O; Borovickova L; Slaninová J
    J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A structurally unique, potent, and selective oxytocin antagonist derived from Streptomyces silvensis.
    Pettibone DJ; Clineschmidt BV; Anderson PS; Freidinger RM; Lundell GF; Koupal LR; Schwartz CD; Williamson JM; Goetz MA; Hensens OD
    Endocrinology; 1989 Jul; 125(1):217-22. PubMed ID: 2544402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.
    Manning M; Cheng LL; Stoev S; Wo NC; Chan WY; Szeto HH; Durroux T; Mouillac B; Barberis C
    J Pept Sci; 2005 Oct; 11(10):593-608. PubMed ID: 15880385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor.
    Serradeil-Le Gal C; Valette G; Foulon L; Germain G; Advenier C; Naline E; Bardou M; Martinolle JP; Pouzet B; Raufaste D; Garcia C; Double-Cazanave E; Pauly M; Pascal M; Barbier A; Scatton B; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 2004 Apr; 309(1):414-24. PubMed ID: 14722330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The separate uterotonic and prostaglandin-releasing actions of oxytocin. Evidence and comparison with angiotensin and methacholine in the isolated rat uterus.
    Chan WY
    J Pharmacol Exp Ther; 1980 Jun; 213(3):575-9. PubMed ID: 7205617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
    Reinheimer TM
    BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic action of neurohypophysial peptides: effects of agonists and antagonists and implication of natriuretic receptor.
    Chan WY; Hruby VJ
    J Pharmacol Exp Ther; 1988 Aug; 246(2):597-602. PubMed ID: 2969979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an oxytocin antagonist on plasma oxytocin levels during nocturnal uterine contractions in the pregnant baboon.
    An TH; Song CH; Choi BC; Pak SC; Mehendale R; Flouret G
    Gynecol Endocrinol; 2002 Jun; 16(3):173-8. PubMed ID: 12192888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin agonist activity of a novel, potent oxytocin antagonist.
    Pettibone DJ; Clineschmidt BV; Lis EV; Ransom RW; Totaro JA; Young GS; Bock MG; Freidinger RM; Veber DF; Williams PD
    Eur J Pharmacol; 1991 Apr; 196(3):233-7. PubMed ID: 1893911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat.
    Lundin S; Broeders A; Ohlin M; Hansson K; Bengtsson HI; Trojnar J; Melin P
    J Pharmacol Exp Ther; 1993 Feb; 264(2):783-8. PubMed ID: 8437126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SK&F 105494, a V2-vasopressin receptor antagonist, blocks oxytocin receptors in porcine myometrium.
    Yu H; Hsu WH
    Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):365-8. PubMed ID: 9812726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor.
    Williams PD; Anderson PS; Ball RG; Bock MG; Carroll L; Chiu SH; Clineschmidt BV; Culberson JC; Erb JM; Evans BE
    J Med Chem; 1994 Mar; 37(5):565-71. PubMed ID: 8126695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor.
    Chan WY; Wo NC; Cheng LL; Manning M
    J Pharmacol Exp Ther; 1996 May; 277(2):999-1003. PubMed ID: 8627583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation to pregnancy leads to attenuated rat uterine artery smooth muscle sensitivity to oxytocin.
    Vedernikov YP; Betancourt A; Wentz MJ; Saade GR; Garfield RE
    Am J Obstet Gynecol; 2006 Jan; 194(1):252-60. PubMed ID: 16389040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the development of oxytocin antagonists for use in preterm labor.
    Pettibone DJ; Guidotti M; Harrell CM; Jasper JR; Lis EV; O'Brien JA; Reiss DR; Woyden CJ; Bock MG; Evans BE
    Adv Exp Med Biol; 1995; 395():601-12. PubMed ID: 8714024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.